Subcutaneous epcoritamab with rituximab + lenalidomide (R(2)) in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial Meeting Abstract
| Authors: | Falchi, L.; Leppä, S.; Wahlin, B. E.; Nijland, M.; Christensen, J. H.; De Vos, S.; Holte, H.; Linton, K. M.; Abbas, A.; Wang, L. W.; Dinh, M.; Elliott, B.; Belada, D. |
| Abstract Title: | Subcutaneous epcoritamab with rituximab + lenalidomide (R(2)) in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | hematologic malignancy; lymphoma; follicular lymphoma; non-hodgkin; phase i/ii; bispecific; ibcl |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S392 |
| Language: | English |
| ACCESSION: | WOS:000897948100444 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01565-8 |
| Notes: | Meeting Abstract: IBCL-460 -- Source: Wos |
